
ImunoTera
São Paulo, Brazil · en.imunotera.com.br
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
ImunoTera develops therapeutic vaccines and other immunotherapies for cancer and infectious diseases. It is based at InovaHC in Brazil and was founded by scientists trained at USP.
Their website has a general contact form; we send your quote request through it.
What they offer
Act-Tera platform
A recombinant-protein biotechnology platform designed with high therapeutic precision to combat various types of cancer.
Therapeutic vaccine development
Develops therapeutic vaccines that can be applied through different immunological strategies.
DNA vaccine development
Applies the platform as a DNA vaccine approach.
Protein vaccine development
Applies the platform as a protein vaccine approach.
RNA vaccine development
Applies the platform as an RNA vaccine approach.
Cell therapy development
Applies the platform as a cell therapy approach.
What they work on
- Modalities
- Cell therapy, Recombinant protein, Vaccine
- Therapeutic areas
- cancer, infectious diseases
- Serves
- Brazil, global market
- Founded
- 2016
Similar labs. 3C Therapeutics, Abnova, AbTherx, AGC Biologics
Found in a contract services directory. Listing built from en.imunotera.com.br. Work here? Claim this listing.